Aviragen Therapeutics, Inc. 4
4 · Aviragen Therapeutics, Inc. · Filed May 22, 2017
Insider Transaction Report
Form 4
Richard John P
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-05-18$0.49/sh+20,000$9,800→ 105,000 totalExercise: $0.49From: 2018-05-18Exp: 2027-05-18→ Common Stock (20,000 underlying)